Mia Wadelius

Uppsala University — Sweden

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

51h-index12.4kcitations168works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(65), Hormonal Regulation and Hypertension(26), Drug Transport and Resistance Mechanisms(15), Atrial Fibrillation Management and Outcomes(14), Coagulation, Bradykinin, Polyphosphates, and Angioedema(14)

Publications167 total

Evaluating <scp>IL1RA</scp>‐Autoantibodies Across <scp>SARS</scp>‐<scp>CoV</scp>‐2‐Related Diseases
Scandinavian Journal of Immunology·2025· 2 citedOpen Access
Response commentary: genome‑wide association study of direct oral anticoagulants and their relation to bleeding
European Journal of Clinical Pharmacology·2025Open Access
Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination
npj Vaccines·2025· 1 citedOpen Access
Pharmacogenomics in pediatric oncology patients with solid tumors related to chemotherapy-induced toxicity: A systematic review
Critical Reviews in Oncology/Hematology·2025· 4 citedOpen Access
Precision Omics Initiative Sweden (PROMISE) will integrate research with healthcare
Nature Medicine·2025· 1 cited
Genome-wide association study of direct oral anticoagulants and their relation to bleeding
European Journal of Clinical Pharmacology·2025· 3 citedOpen Access
Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination
Scientific Reports·2024· 3 citedOpen Access
Gene-based association analysis of a large patient cohort provides insights into genetics of atypical femur fractures
Journal of Bone and Mineral Research·2024· 2 citedOpen Access
Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel
Genes Chromosomes and Cancer·2024· 4 citedOpen Access
Technological readiness and implementation of genomic-driven precision medicine for complex diseases
UNC Libraries·2024Open Access
Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs
PLoS ONE·2024Open Access
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines
npj Vaccines·2024· 7 citedOpen Access
Meta-analysis of ACE inhibitor–induced angioedema identifies novel risk locus
Journal of Allergy and Clinical Immunology·2024· 13 citedOpen Access
Identification of risk factors for adverse drug reactions in a pharmacovigilance database
Pharmacoepidemiology and Drug Safety·2024Open Access
Precision Omics Initiative Sweden (PROMISE): A New Model for Biomedical Research
SSRN Electronic Journal·2024· 2 citedOpen Access
Identification of risk factors for adverse drug reactions in a pharmacovigilance database
Pharmacoepidemiology and Drug Safety·2023· 2 citedOpen Access
Implementing precision medicine in a regionally organized healthcare system in Sweden
Nature Medicine·2022· 41 cited
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
Frontiers in Genetics·2022· 18 citedOpen Access
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate
Pharmacogenomics·2022· 9 citedOpen Access
Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes
Frontiers in Genetics·2022· 12 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Munir Pirmohamed(19), Niclas Eriksson(11), Ann K. Daly(11), Anke H. Maitland‐van der Zee(10), Anders Rane(10), Teri E. Klein(9), Pär Hallberg(9), Claes Wadelius(8), Panos Deloukas(7), M. Isabel Lucena(7), Li Gong(6), Paola Nicoletti(6), Guruprasad P. Aithal(6), Einar S. Björnsson(6), Raúl J. Andrade(6), Andrea Jorgensen(5), Hugo Kohnke(5), Stuart A. Scott(5), Brian F. Gage(5), Jonatan D. Lindh(5)